Home  /  Resource Library  /  Advances in CD30 and PD-1-targeted therapies for classical Hodgkin lymphoma

Advances in CD30 and PD-1-targeted therapies for classical Hodgkin lymphoma

Video round table discusses current treatments for Hodgkin lymphoma.